Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
The clinical evidence behind GLP-1 active compounds as a class is substantial, drawn from large, controlled trials of FDA-approved formulations
A structured retatrutide dosing schedule allows gradual dose increases, which improves tolerability and helps reduce common side effects during treatment
Support long-term weight management, which can reduce strain on the heart
Hydration and nutrition
The half-life of TZT is 5 days, the expected steady state is 45 weeks, body clearance is 0.028 L/h, and the volume of distribution is 5.27L
US$ 28.44
US$ 29.38
US$ 27.28
US$ 22.49
US$ 22.76
US$ 29.87
US$ 26.85
